Article
Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
The Journal of infectious diseases - 1 Dec 1997
Karron R A, Wright P F, Crowe J E, Clements-Mann M L, Thompson J, Makhene M, Casey R, Murphy B R
Abstract excerpt
Two live-attenuated, cold-passaged (cp), temperature-sensitive (ts) candidate vaccines, designated cpts530/1009 and cpts248/955, were attenuated, genetically stable, and immunogenic in chimpanzees and were highly attenuated for human adults. In respiratory syncytial virus (RSV)-seropositive children, cpts530/1009 was more restricted in replication than cpts248/955. In seronegative children, 10(4) pfu of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
